Table 4.
Follow-up characteristics and survival data of 370 women.
| Characteristics | Number of Cases (%) |
|---|---|
| Follow up | |
| Patients lost at follow-up | 4 (1%) |
| Median (months)—total | 34.2 (32.2–36.1) |
| Median (months)—p53abn | 22.2 (15.4–29.0) |
| Median (months)—p53wt | 34.9 (32.9–36.8) |
| Recurrence total | |
| Yes | 13 (3.6%) |
| No | 353 (96.4%) |
| Recurrence p53abn | |
| Yes | 2 (11.1%) |
| No | 16 (88.9%) |
| Recurrence p53wt | |
| Yes | 11 (3.1%) |
| No | 341 (96.3%) |
| DFS p53abn patients | |
| Median (months) | 21.8 (95% CI 15.4–29.0) |
| DFS p53wt patients | |
| Median (months) | 34.2 (95% CI 32.6–36.6) |
| OS p53abn patients | |
| Median (months) | 21.9 (95% CI 16.4–30.1) |
| OS p53wt patients | |
| Median (months) | 34.2 (95% CI 33.2–37.0) |
| Last follow-up status | |
| Alive without disease | 359 (98.1%) |
| Alive with disease | 3 (0.8%) |
| Dead of disease | 1 (0.3%) |
| Dead of other cause | 3 (0.8%) |
| Sites of recurrence | |
| Vaginal cuff | 6 (46.1%) |
| Isolated pelvic peritoneal | 2 (15.4%) |
| Pelvic nodes | 1 (7.7%) |
| Para-aortic nodes | 1 (7.7%) |
| Isolated parenchymatous | 2 (15.4%) |
| Extra abdominal | 1 (7.7%) |
| Therapy at recurrence | |
| RT | 4 (30.8%) |
| CHT | 1 (7.7%) |
| Surgery | 3 (23.0%) |
| Surgery + RT | 4 (30.8%) |
| Surgery + RT + CHT | 1 (7.7%) |
| Response to therapy at recurrence | |
| Complete response | 9 (69.2%) |
| Partial response | 2 (15.4%) |
| Stable disease | 1 (7.7%) |
| Progression | 1 (7.7%) |
RT = radiotherapy; CHT = chemotherapy; DFS = disease-free survival; OS = overall survival.